Policy Holder
Hospital
Insurer
Corporate
Govt Schemes
Blog
Contact
Sign In
Retail Policyholder

Portal for Retail Policyholder to manage your claims and health benefits.

Corporate Employee

Portal for Corporate Employee to manage your claims and health benefits.

Corporate HR

A Corporate HR portal to view and manage employee’s claims

Provider

A Hospital Portal to manage property and it's claims

Insurer

An Insurer portal to manage claims

Agent

An Agent portal to manage customer claims

Broker

Covid-19 XBB.1.16 Variant : A Closer Look

Dear Readers,

The emergence of new variants of Covid-19 has become a major cause for concern around the world. One of the latest variants is the XBB.1.16 variant, which is highly transmissible and has the ability to bypass hybrid immunity obtained by vaccination and prior exposure to the virus. In this article, we will take a closer look at this new variant, including its symptoms, how it differs from other strains of Covid-19, who is at risk of being infected, and what can be done to prevent its spread. It is important to note that while the information presented in this article is based on globally accepted guidelines, it is always best to consult with a healthcare professional for personalized medical advice.

Here are some key questions and answers about this new strain:

What is the XBB.1.16 variant?

The XBB.1.16 sub variant is a highly contagious variant with a high rate of infectivity. According to the World Health Organization, the new variant is "one to watch." Maria Van Kerkhove, WHO's COVID-19 technical head, says that the variant features an extra mutation in the spike protein, which has been shown in lab experiments to increase pathogenicity and infectivity. Hence, one of the many concerns is the potential of the virus to change and become more transmissible and severe.

How is the XBB.1.16 variant different from other strains of Covid-19?

One of the main differences between the XBB.1.16 variant and other strains of Covid-19 is its higher level of transmissibility. This means that it is more easily spread from person to person, and can cause outbreaks to occur more quickly. The shorter incubation period of this variant may also make it more difficult to identify and control outbreaks, as symptoms may appear more quickly and be less severe. Due to its high contagiousness and quick propagation, the mutant SARS CoV 2 strain in XBB.1.16, which is predominantly of Omicron, skillfully avoids the immune system. 

Symptoms of the XBB.1.16 variant

The symptoms of the XBB.1.16 variant are similar to those of other strains of Covid-19 and may include:

  • Upper respiratory infection
  • High grade fever for more than 48 hours
  • Sore throat
  • Cough and cold
  • Body pain
  • Severe headache,
  • Abdominal discomfort
  • Stomach-related issues such as diarrhea and vomiting

Can the XBB.1.16 variant reinfect individuals who have been vaccinated?

There is some evidence that the XBB.1.16 variant may have the ability to reinfect individuals who have already been vaccinated, although the vaccines available are still effective at preventing severe illness and death from Covid-19. It is not yet clear how common reinfection with the XBB.1.16 variant may be, or whether it may cause milder symptoms in vaccinated individuals.

Who is at risk of being infected with the XBB.1.16 variant?

Anyone can be infected with this variant, but some individuals may be at higher risk. These includes:

  • Unvaccinated individuals
  • Children
  • Elderly people
  • Pregnant women
  • Persons with comorbidities such as uncontrolled diabetes, cancer, kidney and heart diseases, etc.

Are the existing vaccines still effective against the XBB.1.16 variant?

The vaccines currently available are still effective at preventing severe illness and death from Covid-19. However, it is possible that vaccinated individuals may still be at risk of contracting this variant and experiencing milder symptoms. It is not yet clear how common reinfection with the XBB.1.16 variant may be.

Are the current tests effective in detecting the infection?

Current tests for detecting Covid-19 are RT-PCR, Rapid Antigen, CRP, etc, which are effective at identifying the presence of the virus in individuals who are infected. However, it is important to note that there may be a delay between the time of infection and the detection of the virus by testing, and that false negative results are possible.

What can be done to prevent the spread of the XBB.1.16 variant?

The basic prevention measures that have been recommended to reduce the risk of contracting and spreading Covid-19, such as wearing masks, practicing social distancing, and regularly washing your hands, remain important in preventing the spread of the virus. It is also important to continue getting vaccinated when a vaccine becomes available to you. If you or someone you know experiences symptoms of Covid-19, it is important to self-isolate and get a Covid-19 test as soon as possible.

Precautionary measures to prevent the spread of the XBB.1.16 variant

There are several steps that you can take to reduce the risk of contracting the XBB.1.16 variant and to prevent its spread to others. These include:

  • Wearing a mask: Masks help to prevent respiratory droplets from spreading when you talk, sneeze, or cough.
  • Social distancing: Staying at least 6 feet away from others can help to reduce the risk of transmission.
  • Hand sanitization: Regularly washing your hands with soap and water or using hand sanitizer can help to kill the virus.
  • Taking booster doses: If you have already been vaccinated, consider getting a booster dose to provide additional protection against the virus.
  • Self-isolation: If you or someone you know experiences any symptoms of Covid-19, it's important to self-isolate and get a Covid-19 test as soon as possible.

It's normal to feel anxious and fearful during the pandemic, but by following these simple precautionary measures, you can reduce your risk of contracting the XBB.1.16 variant and help to protect yourself and others.

In conclusion, the XBB.1.16 variant is a highly transmissible strain of Covid-19 with a shorter incubation period and the potential to reinfect vaccinated individuals. At a recent press briefing, Maria Van Kerkhove, PhD, the WHO's technical lead for COVID-19, said that XBB.1.16 edged out other variants in India. The chances for the virus to propagate is much faster. To protect yourself and your loved ones, one must keep up with the Covid acceptable behavior, such as masking and good hand hygiene. To prevent complications, one must separate themselves if they have any travel history or sickness symptoms. If you or someone you know experiences symptoms of Covid-19, self-isolate and get a test as soon as possible.

References -

  • https://who.canto.global/s/G2PIS?viewIndex=0&column=video&id=4tt7vem1qh3kd4drk88f6b2e1k
  • https://www.cidrap.umn.edu/covid-19/who-tracking-omicron-xbb116-subvariant-rising-cases-some-countries
  • Data as per INSACOG reports

    You may also like

    Research Paper Writing Service - Hiring Professional Writers

    ucr-in-health-insurance.png

    UCR in health insurance


    General helpline 0120 693 7324

    Senior citizen helpline 1800 419 9493

    Chat with us on WhatsApp

    HOSPITALIZATION
    • Plan Hospitalization
    • Locate Hospital
    • Download: eCard | Claim Forms
    • Intimate Claim
    • Track Claim
    • FAQ's
    SIGN IN
    • Retail Policyholder
    • Corporate Employee
    • Provider
    • Insurer
    • Corporate HR
    • Agent
    • Broker
    ABOUT
    • Medi Assist
    • Leadership
    • Contact
    • News & Awards
    • Career
    LEGAL & COMPLIANCE
    • Certificates
    • Policy
    • Compliance & Public disclosure
    • SLA & Grievance Redressal Mechanism

    Download the MAvencare app

    © 2023 Medi Assist Insurance TPA Pvt. Ltd.